Navigation Links
Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis
Date:7/14/2014

ed during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.
  • Nursing Mothers: Because of the potential for serious adverse reactions from methotrexate in breast fed infants, Rasuvo is contraindicated in nursing mothers.
  • Alcoholism or Liver Disease: Patients with alcoholism, alcoholic liver disease or other chronic liver disease.
  • Immunodeficiency Syndromes: Patients who have overt or laboratory evidence of immunodeficiency syndromes.
  • Preexisting Blood Dyscrasias: Patients who have preexisting blood dyscrasias, such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or significant anemia.
  • Hypersensitivity: Patients with a known hypersensitivity to methotrexate. Severe hypersensitivity reactions have been observed with methotrexate use.
  • WARNINGS AND PRECAUTIONS

    • Organ System Toxicity: Rasuvo has the potential for serious toxicity. Rasuvo should be used only by physicians whose knowledge and experience include antimetabolite therapy. Because of the possibility of severe toxic reactions (which can be fatal), Rasuvo should be used only in patients with psoriasis or rheumatoid arthritis with severe, recalcitrant, disabling disease, which is not adequately responsive to other forms of therapy.
    • Embryo-Fetal Toxicity: Methotrexate has been reported to cause fetal death and/or congenital anomalies. Rasuvo is not recommended for females of childbearing potential unless there is clear medical evidence that the benefits can be expected to outweigh the considered risks.  Rasuvo is contraindicated in pregnant women with psoriasis or rheumatoid arthritis. Exclude pregnancy before treatment. Females should be counseled on the serious risks to the fetus should they become pregnant while undergoing treatment.  Avoid pregnancy if either partner is receiving Ra
      '/>"/>

    SOURCE Medac Pharma, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting
    2. Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
    3. Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical
    4. Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana
    5. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM
    6. Pre-Market Analysis: MannKind, Galena Biopharma, Ariad Pharma, and Novavax
    7. Todays Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn
    8. Stipulation Of Dismissal Of Claims By Plaintiff Cornerstone Biopharma, Inc.
    9. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
    10. NovoBioPharma, Partnership of Top Life Science Experts, Launches
    11. Zosano Pharma, Inc. Appoints Nandan Oza as Chief Operations Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... , Sept. 2, 2015 This ... studies the current and future prospects of the ... patient,s health and assists medical practitioners in deciding ... disease progression during treatment. Multi-parameter patient monitoring is ... chronic disease. Geriatric population is observed to be ...
    (Date:9/2/2015)... YORK , Sept. 2, 2015 ... is an X-linked disease, which generally affects the ... degeneration and weakness. The disease is caused due ... in the lack of production of dystrophin (a ... individuals. The lack of dystrophin weakens muscle function, ...
    (Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
    Breaking Medicine Technology:Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6
    (Date:9/2/2015)... ... September 03, 2015 , ... One can hardly argue ... frequency than they do laptops and personal computers. These devices are being used as ... and the revolution of mobile dating apps, STD positive singles can now join the ...
    (Date:9/2/2015)... ... September 02, 2015 , ... ... Warrior-Family Symposium (WFS), cosponsored by the Military Officers Association of America (MOAA) ... event, "Our Nation's Military: Caring For Our Own,” expert panelists will lead ...
    (Date:9/2/2015)... ... 02, 2015 , ... The Western Connecticut Health Network (WCHN) ... Trust to establish the Abraham and Mildred Goldstein Endowment Fund for Ovarian Cancer ... nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD as its network physician ...
    (Date:9/2/2015)... ... September 02, 2015 , ... RxNT , an ... of its enhanced, cloud-based mobile ePrescribing application. The release of this enhanced iPhone ... usability. A leader in health technology, RxNT was one of the first to ...
    (Date:9/2/2015)... ... September 02, 2015 , ... The medical waste management ... in 2015, at a CAGR of 5.2%. The global medical waste management market is ... treatment and disposal segment is expected to register the highest growth rate in the ...
    Breaking Medicine News(10 mins):Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5
    ... Creates Explosive Growth for Domestic and, International ... Reach $5.974 Billion With ... ANGELES, May 20 With another sweltering summer,forecast for ... are,driving growth in the burgeoning, multi-billion dollar bottled water,industry ...
    ... wins multi-million dollar, multi-year technology ... Medical Center, Biloxi, MS, HOUSTON, May 20 Shipcom ... announced today,that they have been selected by the Air Force ... across the Air Force Medical,Service and then pilot RFID systems ...
    ... Patients the Ability to Share their Prescription History, ... Drug,Stores Corporation (NYSE: LDG ) announced today ... platform for sharing of information between,patients and providers. ... the first,pharmacies to provide their customers with the ...
    ... TX According to the 2000 census, Americans office ... at their desks or work stations. Many recent studies ... longer hours in office environments, often under artificial light ... stress levels. , How can employers make office environments ...
    ... May 19 Six years ago,Senator Patty Murray ... and invest federal funding in the research critically ... mesothelioma, and,other asbestos related diseases. Since 2002, the ... with Senator,Murray to stop the death and suffering ...
    ... Standard Therapy for Eradicating H. pylori , An ... and standard triple therapies in patients with documented, ... sequential therapy appears superior to standard triple therapy ... Authors say if further trials confirm these findings, ...
    Cached Medicine News:Health News:H2O = Big Business in a Bottle 2Health News:H2O = Big Business in a Bottle 3Health News:H2O = Big Business in a Bottle 4Health News:H2O = Big Business in a Bottle 5Health News:H2O = Big Business in a Bottle 6Health News:H2O = Big Business in a Bottle 7Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 2Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 3Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 4Health News:Longs Drugs Partners With Google on the Launch of Google Health 2Health News:Greener offices make happier employees 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 3Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 4
    Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
    ... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
    ... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
    ... digital models cover the range from 2ul to ... Volume lock design prevents inadvertent volume change. ... grip. Whole pipette is autoclavable at 121C(250F). ... all polypropylene. Suitable for one-handed operation. ...
    Medicine Products: